Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Daniel on +44 1494 818 028 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Daniel Newbury
Senior Account Manager
+44 1494 818 028

I have been in touch with Zenopa for a few years now whilst I was trying to get myself into the Medical Sales Industry.
Lisa, 2011

Quintiles launches digital patient unit

4 January 2012 00:00 in Marketing Services

Quintiles has announced the launch of its digital patient unit, a new organisation that aims to provide patients with information on personal health management.

The unit combines the biopharmaceutical services provider's online communities and digital expertise to provide people with more opportunities to participate in clinical research, observational studies and other programmes that can help in the management of various conditions.

Central to the new offering is the company's existing patient communities at and, which provide members with guidance on drug safety issues and the availability of local trials.

David Coman, senior vice-president at Quintiles and head of the new digital patient unit, said this move reflects the fact that people are increasingly likely to use the internet as a resource to find out more about their health.

"We will be better able to ... provide our customers with a more efficient channel to find the appropriate people who may be interested in participating in clinical, observational or disease management programmes," he said.

Last month, the company announced a new partnership with drugmaker Intarcia Therapeutics pertaining to the development of a new therapy for diabetes.ADNFCR-8000103-ID-801255166-ADNFCR

Other news stories from 04/01/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd